Literature DB >> 21466255

Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia.

Niclas Johansson1, Mats Kalin, Jonas Hedlund.   

Abstract

BACKGROUND: New methods for identifying respiratory pathogens have led to several reports of a high yield of mixed infections in patients with community-acquired pneumonia (CAP). The clinical impact of these findings has, however, not been fully evaluated. We aimed to compare patients with a pure bacterial etiology with those with findings of both bacteria and virus regarding severity of illness and length of hospital stay.
METHODS: Adults with CAP admitted to Karolinska University Hospital were studied prospectively (N = 184). Microbiological methods included cultures from blood, sputum and nasopharyngeal secretions; sputum samples analyzed with quantitative real-time polymerase chain reaction for Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis; nasopharyngeal specimens analyzed with polymerase chain reaction and serology for Mycoplasma pneumoniae, Chlamydophila pneumoniae and viruses common in the respiratory tract; and urine antigen assays for detecting pneumococcal and Legionella pneumophila antigens. The pneumonia severity index (PSI) was used to assess the severity of illness.
RESULTS: The likelihood of getting a score corresponding to PSI classes IV or V was higher in patients with findings of both bacteria and virus than in those with a bacterial pathogen alone (odds ratio 4.98, 95% confidence interval 2.09-11.89; p < 0.001). The median length of hospital stay was 7 days among patients with mixed infections and 4 days among those with a bacterial etiology alone (p = 0.018).
CONCLUSIONS: Patients infected with a virus and a bacterial pathogen more often develop severe CAP and have a longer hospitalization than those with a bacterial etiology alone.

Entities:  

Mesh:

Year:  2011        PMID: 21466255     DOI: 10.3109/00365548.2011.570785

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  35 in total

1.  Duration of Stay of Patients with Community-Acquired Pneumonia in Influenza Season.

Authors:  Emel Tellioğlu; Günseli Balcı; Aydan Mertoğlu
Journal:  Turk Thorac J       Date:  2018-06-12

Review 2.  [Respiratory syncytial virus].

Authors:  Jürgen Seidenberg
Journal:  Internist (Berl)       Date:  2019-11       Impact factor: 0.743

Review 3.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

4.  Evaluation of tuberculosis infection in COVID-19 patients: a case of tuberculosis and COVID-19 co-infection.

Authors:  Hamid Reza Niazkar; Behdad Zibaee; Seyed Behzad Razavi; Kasra Ghanaeian; Vahid Talebzadeh; Negin Haji Vosugh
Journal:  Egypt J Intern Med       Date:  2022-06-02

5.  Polymicrobial acute respiratory infections in a hospital-based pediatric population.

Authors:  Margaret L Chorazy; Mark G Lebeck; Troy A McCarthy; Sandra S Richter; James C Torner; Gregory C Gray
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

6.  Clinical Evaluation of the New High-Throughput Luminex NxTAG Respiratory Pathogen Panel Assay for Multiplex Respiratory Pathogen Detection.

Authors:  Jonathan H K Chen; Ho-Yin Lam; Cyril C Y Yip; Sally C Y Wong; Jasper F W Chan; Edmond S K Ma; Vincent C C Cheng; Bone S F Tang; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2016-04-27       Impact factor: 5.948

7.  Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients.

Authors:  Yingzhi Liu; Lowell Ling; Sunny H Wong; Maggie Ht Wang; J Ross Fitzgerald; Xuan Zou; Shisong Fang; Xiaodong Liu; Xiansong Wang; Wei Hu; Hung Chan; Yan Wang; Dan Huang; Qing Li; Wai T Wong; Gordon Choi; Huachun Zou; David Sc Hui; Jun Yu; Gary Tse; Tony Gin; William Kk Wu; Matthew Tv Chan; Lin Zhang
Journal:  EClinicalMedicine       Date:  2021-06-10

8.  Detection of viral and bacterial pathogens in hospitalized children with acute respiratory illnesses, Chongqing, 2009-2013.

Authors:  Lan Wei; Wei Liu; Xiao-Ai Zhang; En-Mei Liu; Yin Wo; Benjamin J Cowling; Wu-Chun Cao
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 9.  An evaluation of the emerging vaccines against influenza in children.

Authors:  Harish Nair; Eva Lau; W Brooks; Ang Seong; Evropi Theodoratou; Lina Zgaga; Tanvir Huda; Suresh S Jadhav; Igor Rudan; Harry Campbell
Journal:  BMC Public Health       Date:  2013-09-17       Impact factor: 3.295

Review 10.  What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?

Authors:  Andrew T Pavia
Journal:  Infect Dis Clin North Am       Date:  2012-12-12       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.